Inscrição na biblioteca: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publicou 6 edições por ano

ISSN Imprimir: 1045-4403

ISSN On-line: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Targeting the Regulatory Machinery of BIM for Cancer Therapy

Volume 22, Edição 2, 2012, pp. 117-129
DOI: 10.1615/CritRevEukarGeneExpr.v22.i2.40
Get accessGet access

RESUMO

BIM represents a BH3-only proapoptotic member of the BCL-2 family of apoptotic regulatory proteins. Recent evidence suggests that in addition to its involvement in normal homeostasis, BIM plays a critical role in tumor cell biology, including the regulation of tumorigenesis through activities as a tumor suppressor, tumor metastasis, and tumor cell survival. Consequently, BIM has become the focus of intense interest as a potential target for cancer chemotherapy. The control of BIM expression is complex, and involves multiple factors, including epigenetic events (i.e., promoter acetylation or methylation, miRNA), transcription factors, posttranscriptional regulation, and posttranslational modifications, most notably phosphorylation. Significantly, the expression of BIM by tumor cells has been shown to play an important role in determining the response of transformed cells to not only conventional cytotoxic agents, but also to a broad array of targeted agents that interrupt cell signaling and survival pathways. Furthermore, modifications in BIM expression may be exploited to improve the therapeutic activity and potentially the selectivity of such agents. It is likely that evolving insights into the factors that regulate BIM expression will ultimately lead to novel BIM-based therapeutic strategies in the future.

CITADO POR
  1. Ye Ping, Zhao Liang, McGirr Crystal, Gonda Thomas J, MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo, Cancer Letters, 343, 1, 2014. Crossref

  2. Pan Bo, Yang Lifeng, Wang Jin, Wang Yunsheng, Wang Jihong, Zhou Xiangmei, Yin Xiaomin, Zhang Zhongqiu, Zhao Deming, c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis, Molecular Neurobiology, 49, 2, 2014. Crossref

  3. Denoyelle C, Lambert B, Meryet-Figuière M, Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis M-H, Gauduchon P, Juin P, Poulain L, miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation, Cell Death & Disease, 5, 10, 2014. Crossref

  4. Castellano Paul, Prevedel Lisa, Eugenin Eliseo A., HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim, Scientific Reports, 7, 1, 2017. Crossref

  5. Ramezani Samaneh, Shirdel Abbas, Rafatpanah Houshang, Akbarin Mohammad Mehdi, Tarokhian Hanieh, Rahimi Hossein, Bari Alireza, Jahantigh Hamid Reza, Rezaee Seyed Abdolrahim, Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma, Medical Microbiology and Immunology, 206, 4, 2017. Crossref

  6. Sammons Rachel M., Ghose Ranajeet, Tsai Kenneth Y., Dalby Kevin N., Targeting ERK beyond the boundaries of the kinase active site in melanoma, Molecular Carcinogenesis, 58, 9, 2019. Crossref

  7. Tomicic Maja T., Meise Ruth, Aasland Dorthe, Berte Nancy, Kitzinger Rebekka, Krämer Oliver H., Kaina Bernd, Christmann Markus, Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM, Oncotarget, 6, 32, 2015. Crossref

  8. Li Lu, Sheng Peike, Li Tianqi, Fields Christopher J., Hiers Nicholas M., Wang Yuzhi, Li Jianping, Guardia Casey M., Licht Jonathan D., Xie Mingyi, Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins, Genes & Development, 35, 23-24, 2021. Crossref

  9. Liu Zhongwei, Shah Neal, Marshall Kent L., Sprowls Samuel A., Saralkar Pushkar, Mohammad Afroz, Blethen Kathryn E., Arsiwala Tasneem A., Fladeland Ross, Lockman Paul R., Gao Weimin, Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo, Archives of Toxicology, 95, 11, 2021. Crossref

  10. Shadbad Mahdi Abdoli, Hajiasgharzadeh Khalil, Derakhshani Afshin, Silvestris Nicola, Baghbanzadeh Amir, Racanelli Vito, Baradaran Behzad, From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past, Frontiers in Immunology, 12, 2021. Crossref

  11. Anderson Gray R., Wardell Suzanne E., Cakir Merve, Crawford Lorin, Leeds Jim C., Nussbaum Daniel P., Shankar Pallavi S., Soderquist Ryan S., Stein Elizabeth M., Tingley Jennifer P., Winter Peter S., Zieser-Misenheimer Elizabeth K., Alley Holly M., Yllanes Alexander, Haney Victoria, Blackwell Kimberly L., McCall Shannon J., McDonnell Donald P., Wood Kris C., PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation , Science Translational Medicine, 8, 369, 2016. Crossref

  12. Labrie Marilyne, Brugge Joan S., Mills Gordon B., Zervantonakis Ioannis K., Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer, Nature Reviews Cancer, 22, 6, 2022. Crossref

  13. Hata Aaron N., Engelman Jeffrey A., Faber Anthony C., The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics, Cancer Discovery, 5, 5, 2015. Crossref

  14. Xue Wu, Xue Fan, Jia Tao, Hao Ai, Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology, Bioengineered, 13, 4, 2022. Crossref

  15. Suyama Kimita, Yao Jiahong, Liang Huizhi, Benard Outhiriaradjou, Loudig Olivier D., Amgalan Dulguun, McKimpson Wendy M., Phillips Greg R., Segall Jeffrey, Wang Yihong, Fineberg Susan, Norton Larry, Kitsis Richard N., Hazan Rachel B., An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary Tumorigenesis, Cancer Research, 78, 1, 2018. Crossref

  16. Farghadani Reyhaneh, Naidu Rakesh, The Role of Apoptosis as a Double-Edge Sword in Cancer, in Regulation and Dysfunction of Apoptosis, 2022. Crossref

  17. Heisey Daniel A.R., Lochmann Timothy L., Floros Konstantinos V., Coon Colin M., Powell Krista M., Jacob Sheeba, Calbert Marissa L., Ghotra Maninderjit S., Stein Giovanna T., Maves Yuki Kato, Smith Steven C., Benes Cyril H., Leverson Joel D., Souers Andrew J., Boikos Sosipatros A., Faber Anthony C., The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity, Clinical Cancer Research, 25, 5, 2019. Crossref

  18. Wang Rui, Li Ying, Gong Ping, Gabrilove Janice, Waxman Samuel, Jing Yongkui, Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells, Molecular Cancer Therapeutics, 17, 9, 2018. Crossref

  19. Liu Xiu Fen, Xiang Laiman, Zhou Qi, Carralot Jean-Philippe, Prunotto Marco, Niederfellner Gerhard, Pastan Ira, Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis, Proceedings of the National Academy of Sciences, 113, 38, 2016. Crossref

  20. Lopez Andrea, Reyna Denis E., Gitego Nadege, Kopp Felix, Zhou Hua, Miranda-Roman Miguel A., Nordstrøm Lars Ulrik, Narayanagari Swathi-Rao, Chi Ping, Vilar Eduardo, Tsirigos Aristotelis, Gavathiotis Evripidis, Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer, Nature Communications, 13, 1, 2022. Crossref

  21. Mohammadi Zahra, Enayati Somayeh, Zarei Najmeh, Mozhgan Zahmatkesh , Saberi Samaneh, Mafakher Ladan, Azizi Mohammad, Khalaj Vahid, A Novel Anti-CD22 scFv.Bim Fusion Protein Effectively Induces Apoptosis in Malignant B cells and Promotes Cytotoxicity, Applied Biochemistry and Biotechnology, 2022. Crossref

Próximos artigos

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain